Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
Clinical trial NCT06103279 · UNKNOWN
Trial details
- NCT number
- NCT06103279
- Sponsor
- Ain Shams University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.